DexCom Financials
| D1EX34 Stock | BRL 8.00 0.20 2.44% |
DexCom |
Understanding current and past DexCom Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of DexCom's financial statements are interrelated, with each one affecting the others. For example, an increase in DexCom's assets may result in an increase in income on the income statement.
Please note, the presentation of DexCom's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, DexCom's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of DexCom's management manipulating its earnings.
DexCom Stock Summary
DexCom competes with United Airlines, MAHLE Metal, Tyson Foods, and Automatic Data. DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems in the United States and internationally. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California. DEXCOM INC operates under Diagnostics Research classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 5500 people.| Instrument | Brazil Stock View All |
| Exchange | Sao Paulo Exchange |
| Business Address | 6340 Sequence Drive |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Benchmark | Dow Jones Industrial |
| Website | www.dexcom.com |
| Phone | 858 200 0200 |
| Currency | BRL - Brazilian Real |
You should never invest in DexCom without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of DexCom Stock, because this is throwing your money away. Analyzing the key information contained in DexCom's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
DexCom Key Financial Ratios
DexCom's financial ratios allow both analysts and investors to convert raw data from DexCom's financial statements into concise, actionable information that can be used to evaluate the performance of DexCom over time and compare it to other companies across industries.| Return On Equity | 31.66 | |||
| Return On Asset | 5.37 | |||
| Beta | 0.74 | |||
| Z Score | 88.8 |
DexCom Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining DexCom's current stock value. Our valuation model uses many indicators to compare DexCom value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across DexCom competition to find correlations between indicators driving DexCom's intrinsic value. More Info.DexCom Inc is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about 0.17 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for DexCom Inc is roughly 5.90 . Comparative valuation analysis is a catch-all model that can be used if you cannot value DexCom by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for DexCom's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.DexCom Inc Systematic Risk
DexCom's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. DexCom volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on DexCom Inc correlated with the market. If Beta is less than 0 DexCom generally moves in the opposite direction as compared to the market. If DexCom Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one DexCom Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of DexCom is generally in the same direction as the market. If Beta > 1 DexCom moves generally in the same direction as, but more than the movement of the benchmark.
DexCom March 20, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of DexCom help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of DexCom Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of DexCom Inc based on widely used predictive technical indicators. In general, we focus on analyzing DexCom Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build DexCom's daily price indicators and compare them against related drivers.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 15.13 | |||
| Value At Risk | (3.48) | |||
| Potential Upside | 2.36 |
Complementary Tools for DexCom Stock analysis
When running DexCom's price analysis, check to measure DexCom's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DexCom is operating at the current time. Most of DexCom's value examination focuses on studying past and present price action to predict the probability of DexCom's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DexCom's price. Additionally, you may evaluate how the addition of DexCom to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |